• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bilateral breast cancer: one disease or two?

作者信息

Dawson P J, Maloney T, Gimotty P, Juneau P, Ownby H, Wolman S R

机构信息

Department of Pathology, University of Chicago, IL.

出版信息

Breast Cancer Res Treat. 1991 Nov;19(3):233-44. doi: 10.1007/BF01961160.

DOI:10.1007/BF01961160
PMID:1663803
Abstract

Our purpose was to determine whether bilateral breast cancer depends upon genetic predisposition to multiple tumors or, alternatively, represents two independent sporadic events. Biological concordance of hormone receptors and histopathology in bilateral tumors, family history of breast cancer, age at diagnosis, and survival were evaluated in 88 patients. The immunoreactivity of paired tumors from 51 patients to six different immunocytochemical markers was compared. Neither histologic patterns nor immunocytochemical reactions showed concordance between bilateral tumors. Absence of concordance (other than for estrogen receptors) and lack of associations with positive family history and early age of onset support an interpretation of independent tumor origins and does not suggest a major role for genetic determinants in the majority of cases of bilateral breast cancer.

摘要

相似文献

1
Bilateral breast cancer: one disease or two?
Breast Cancer Res Treat. 1991 Nov;19(3):233-44. doi: 10.1007/BF01961160.
2
HER2 as a prognostic factor in breast cancer.HER2作为乳腺癌的一个预后因素。
Oncology. 2001;61 Suppl 2:67-72. doi: 10.1159/000055404.
3
Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score.通过增殖细胞核抗原评分预测乳腺癌患者的早期复发和生存期缩短
Cancer. 1993 Jun 1;71(11):3552-9. doi: 10.1002/1097-0142(19930601)71:11<3552::aid-cncr2820711115>3.0.co;2-n.
4
Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.HAb18G 的表达与乳腺癌的肿瘤进展和预后相关。
Breast Cancer Res Treat. 2010 Dec;124(3):677-88. doi: 10.1007/s10549-010-0790-6. Epub 2010 Mar 9.
5
Luminal B breast tumors are not HER2 positive.管腔B型乳腺肿瘤不是HER2阳性。
Breast Cancer Res. 2008;10(5):404; author reply 405. doi: 10.1186/bcr2134. Epub 2008 Sep 26.
6
A retrospective analysis of breast cancer based on outcome differences.基于结局差异的乳腺癌回顾性分析。
Hum Pathol. 1991 May;22(5):475-80. doi: 10.1016/0046-8177(91)90134-b.
7
Uncovering the genomic heterogeneity of multifocal breast cancer.揭示多灶性乳腺癌的基因组异质性。
J Pathol. 2015 Aug;236(4):457-66. doi: 10.1002/path.4540. Epub 2015 May 7.
8
Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.p53肿瘤抑制基因蛋白的积累:乳腺癌预后的独立标志物。
J Natl Cancer Inst. 1992 Jun 3;84(11):845-55. doi: 10.1093/jnci/84.11.845.
9
Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancer.
Breast Cancer Res Treat. 1990 Nov;17(1):15-21. doi: 10.1007/BF01812680.
10
PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.乳腺癌中PCNA/细胞周期蛋白的表达:其与Ki-67、雌激素受体、孕激素受体免疫染色及临床病理特征的关系
Pathologica. 1993 Jan-Feb;85(1095):47-55.

引用本文的文献

1
Contralateral breast cancer in patients carrying mutations in the BRCA1∕2 gene.携带BRCA1∕2基因突变的患者发生的对侧乳腺癌。
Rom J Morphol Embryol. 2025 Jan-Mar;66(1):111-118. doi: 10.47162/RJME.66.1.10.
2
Synchronous Bilateral Breast Cancer With Discordant Receptor Status: Treating One Patient but Two Diseases.具有不一致受体状态的同步双侧乳腺癌:治疗一名患者,应对两种疾病。
World J Oncol. 2023 Jun;14(3):224-229. doi: 10.14740/wjon1603. Epub 2023 Jun 11.
3
Mitochondrial DNA analysis efficiently contributes to the identification of metastatic contralateral breast cancers.

本文引用的文献

1
BILATERAL PRIMARY BREAST CANCER; A PROSPECTIVE CLINICOPATHOLOGICAL STUDY.双侧原发性乳腺癌;一项前瞻性临床病理研究。
Cancer. 1964 Dec;17:1501-27. doi: 10.1002/1097-0142(196412)17:12<1501::aid-cncr2820171202>3.0.co;2-p.
2
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.乳腺癌的组织学分级与预后;对1409例病例的研究,其中359例已随访15年。
Br J Cancer. 1957 Sep;11(3):359-77. doi: 10.1038/bjc.1957.43.
3
Bilateral carcinoma of the breast.双侧乳腺癌
线粒体 DNA 分析有助于有效地鉴定转移性对侧乳腺癌。
J Cancer Res Clin Oncol. 2021 Feb;147(2):507-516. doi: 10.1007/s00432-020-03459-5. Epub 2020 Nov 24.
4
Synchronous and Metachronous Metastatic Breast Cancer, with Different Histology and Opposite Immunophenotype, Treated with Combination of Chemotherapy, Anti-Her2, and Endocrine Therapy: A Case Report.同步和异时性转移性乳腺癌,组织学不同且免疫表型相反,采用化疗、抗Her2和内分泌治疗联合方案治疗:一例报告
Case Rep Oncol. 2020 May 13;13(2):544-549. doi: 10.1159/000507433. eCollection 2020 May-Aug.
5
Clonal relatedness in tumour pairs of breast cancer patients.乳腺癌患者肿瘤对的克隆相关性。
Breast Cancer Res. 2018 Aug 9;20(1):96. doi: 10.1186/s13058-018-1022-y.
6
Bilateral Metachronous Breast Carcinoma: A Rare Case Report.双侧异时性乳腺癌:一例罕见病例报告
Int J Appl Basic Med Res. 2018 Apr-Jun;8(2):126-128. doi: 10.4103/ijabmr.IJABMR_384_16.
7
Breast-Conserving Surgery in Bilateral Breast Cancer.双侧乳腺癌的保乳手术
Ann Surg Oncol. 2015 Oct;22(10):3389-96. doi: 10.1245/s10434-015-4746-2. Epub 2015 Aug 12.
8
Comparison of the histopathology and prognosis of bilateral versus unilateral multifocal multicentric breast cancers.双侧与单侧多灶性多中心乳腺癌的组织病理学及预后比较。
World J Surg Oncol. 2014 Aug 20;12:266. doi: 10.1186/1477-7819-12-266.
9
Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype.同步性和异时性双侧乳腺癌有区别吗?一项针对肿瘤内在表型的免疫组化分析。
Int J Clin Exp Pathol. 2013 Dec 15;7(1):353-63. eCollection 2014.
10
Endogenous versus tumor-specific host response to breast carcinoma: a study of stromal response in synchronous breast primaries and biopsy site changes.内源性与肿瘤特异性宿主对乳腺癌的反应:同步原发性乳腺癌和活检部位变化中基质反应的研究。
Clin Cancer Res. 2011 Feb 1;17(3):437-46. doi: 10.1158/1078-0432.CCR-10-1709. Epub 2010 Nov 22.
Br J Surg. 1980 Jul;67(7):514-6. doi: 10.1002/bjs.1800670720.
4
Characteristics of familial breast cancer in Sweden: absence of relation to age and unilateral versus bilateral disease.
Cancer. 1981 Oct 1;48(7):1688-95. doi: 10.1002/1097-0142(19811001)48:7<1688::aid-cncr2820480736>3.0.co;2-w.
5
Familial breast cancer and its recognition in an oncology clinic.家族性乳腺癌及其在肿瘤诊所中的识别
Cancer. 1981 Jun 1;47(11):2730-9. doi: 10.1002/1097-0142(19810601)47:11<2730::aid-cncr2820471132>3.0.co;2-8.
6
Bilateral breast cancer in patients with initial stage I and II disease.初始分期为I期和II期疾病患者的双侧乳腺癌。
Cancer. 1982 Sep 15;50(6):1191-4. doi: 10.1002/1097-0142(19820915)50:6<1191::aid-cncr2820500628>3.0.co;2-f.
7
Second primary cancers of the breast: incidence and risk factors.乳腺第二原发性癌:发病率及危险因素
Br J Cancer. 1984 Jan;49(1):79-85. doi: 10.1038/bjc.1984.12.
8
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer.国家乳腺癌辅助手术项目(协议编号4)的病理研究结果。十一、双侧乳腺癌
Cancer. 1984 Dec 15;54(12):3002-11. doi: 10.1002/1097-0142(19841215)54:12<3002::aid-cncr2820541231>3.0.co;2-v.
9
Bilateral primary breast cancer: a prospective study of disease incidence.双侧原发性乳腺癌:疾病发病率的前瞻性研究
Br J Surg. 1984 Sep;71(9):711-4. doi: 10.1002/bjs.1800710924.
10
Pregnancy-specific beta-1 glycoprotein (SP-1) in breast carcinoma. Pathologic and clinical considerations.乳腺癌中的妊娠特异性β-1糖蛋白(SP-1)。病理学及临床考量。
Cancer. 1984 Oct 1;54(7):1392-6. doi: 10.1002/1097-0142(19841001)54:7<1392::aid-cncr2820540727>3.0.co;2-m.